Latest News

Illumina (NASDAQ:ILMN) expects clinical demand and sequencing consumables to remain central to its growth strategy, even as research customers continue to face uncertainty over grant funding, executives said at a UBS discussion. CEO Jacob Thaysen said the company remains on the trajectory outlined

Factorial Energy (NASDAQ:FAC) reported its first commercial revenue in the third quarter of 2026, as the battery developer began shipping cells to a U.S. drone maker ahead of its prior 2027 revenue timeline. The company recorded approximately $26,000 in revenue from the aerospace order announced in

Cumberland Pharmaceuticals (NASDAQ:CPIX) reported third-quarter net income of $77.8 million, reflecting the sale of its commercial products to Apotex Health, and outlined plans to advance its lead drug candidate toward a regulatory submission for Duchenne muscular dystrophy-associated heart disease.

Grocery Outlet (NASDAQ:GO) returned to positive comparable-store sales in the third quarter of 2026 as more shoppers visited its stores, although smaller customer baskets and higher costs continued to weigh on profitability. Net sales rose 0.9% to $1.18 billion for the quarter ended October 3. Comp

Evolv Technologies (NASDAQ:EVLV) reported record third-quarter revenue of $47.3 million, up 10% from a year earlier, and raised the bottom end of its 2026 revenue outlook as its shift toward recurring revenue continued to take hold. The weapons-screening company said annual recurring revenue rose 2

Astronics (NASDAQ:ATRO) reported record third-quarter sales and operating income as higher aerospace demand and an Army radio test program helped lift revenue 28.5% from a year earlier. The company maintained its 2026 revenue forecast and said it expects strong double-digit growth in 2027. Sales ro

Draganfly (NASDAQ:DPRO) reported lower third-quarter revenue and a wider loss as reduced drone services sales and an inventory write-down weighed on results. Management said it had reserved production capacity for defense work and expects revenue growth to accelerate in 2027. Revenue for the quarte

Capricor Therapeutics (NASDAQ:CAPR) is awaiting a Nov. 22 Food and Drug Administration decision on Deramiocel for Duchenne muscular dystrophy, as the company prepares for a potential launch while reporting a wider third-quarter loss. CEO Linda Marbán said on the company’s Nov. 10 earnings call that

Carlsmed (NASDAQ:CARL) raised its full-year revenue outlook after third-quarter sales climbed 65%, as more surgeons adopted its personalized spine surgery products and procedure volume increased. The company reported revenue of $21.6 million for the quarter, up from $13.1 million a year earlier. Pr

Black Rock Coffee Bar (NASDAQ:BRCB) reported a 29.7% increase in third-quarter revenue as customer transactions returned to growth, and the company raised its full-year store opening target while reaffirming its sales and profit outlook. Revenue rose to $66.8 million, while same-store sales increas

These top Canadian dividend stocks have a solid payout history and can help you make steady passive income in all market conditions.

GE Vernova's backlog is large and supports predictable future revenue. However, there is a range of outcomes for its future valuation based on the sustainability of order flows through 2030.

Effective heat control systems are an increasingly vital component of the AI boom.

Plaquemines is now commercial, and CP2 timing just moved up.

Fourth-quarter sales climbed 23% as the company kept acquiring.

After a pullback, AMD’s agentic AI CPU demand and multiyear GPU runway give it a path to beat the market through 2030.

Defense funding and tungsten price spikes reshaped the quarter's results.

Leading edge rates rose again as management set its 2027 outlook.

Customer funding and a strong fourth quarter order book shape the outlook ahead.

Record margins and medical momentum stand out, but a U.K. plant slowdown adds a clear headwind.

Pork weakness and a beef rebound split JBS's segments in opposite directions.

Volume gains in two basins lifted the outlook, while a major pipeline expansion moved forward.

Eaton gets paid before AI generates a dime.

Eve's transition flights advance as Embraer's record backlog keeps growing.

Canaan shifts focus to energy and AI infrastructure as mining demand lags.